サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1761522

家禽用医薬品の世界市場：動物タイプ・製品タイプ・疾患タイプ・投与経路・地域別の機会および予測 (2018-2032年)

Global Poultry Pharmaceuticals Market Assessment, By Animal Type, By Product Type, By Disease Type, By Route of Administration, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 243 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
家禽用医薬品の世界市場：動物タイプ・製品タイプ・疾患タイプ・投与経路・地域別の機会および予測 (2018-2032年)
出版日: 2025年07月03日
発行: Markets & Data
ページ情報: 英文 243 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の家禽用医薬品の市場規模は、2025年から2032年の予測期間中にCAGR 6.17%で推移し、2024年の65億6,000万米ドルから、2032年には105億9,000万米ドルに成長すると予測されています。

家禽用医薬品市場は、動物の健康を支える重要な分野であり、家禽に対する医薬品、健康補助製品、ワクチンなどを開発・供給する役割を担っています。この市場は、家禽の健康を保護し、病気の予防や安全な食肉・卵の生産を実現するうえで重要な役割を果たしています。市場の対象は小規模な生産者だけでなく、商業的な養鶏事業者にもサービスを提供しており、細菌性・ウイルス性疾患、寄生虫病、栄養障害など多様な健康問題に対応しています。

この市場では、抗生物質、抗ウイルス薬、ワクチン、プロバイオティクス、免疫や成長を促進する飼料添加物といった必須製品が提供されています。現在では、抗菌薬耐性への懸念の高まりから、植物由来のフィトジェニック治療薬やワクチン、精密健康管理（プレシジョンヘルス）が重視されるようになっています。また、各国の規制枠組みによって製品の安全性・有効性基準が設定されており、バイオセキュリティ対策によって疾病の発生抑制が図られています。この業界の成長を支える主な要因は2つあります。1つは家禽肉や卵に対する需要の増加と養鶏手法の改善、もう1つは人獣共通感染症に対する理解の進展です。新興国では家禽生産の拡大により市場が急速に拡大しており、先進国では高度な治療ソリューションや持続可能な農業慣行に焦点を当てた成長が進んでいます。将来的には、バイオテクノロジーと診断技術の進展により、より特異的かつ効果的な治療法が開発され、家禽医薬品市場はさらなる発展を遂げると見込まれています。業界は今後も、疾病の制御、生産性の最大化、倫理的な畜産を重視することで、ダイナミックに進化していくでしょう。

当レポートでは、世界の家禽用医薬品の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分別の詳細分析、法規制環境、臨床試験の動向、ケーススタディ、市場成長への影響因子の分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の家禽用医薬品市場の展望

  • 市場規模の分析・予測
  • 市場シェアの分析・予測
    • 動物タイプ別
      • 鶏
      • 七面鳥
      • その他
    • 製品タイプ別
      • 薬剤
      • ワクチン
      • 飼料添加物
    • 疾患タイプ別
      • ニューカッスル病
      • 鳥インフルエンザ
      • コクシジウム症
      • サルモネラ
      • その他
    • 投与経路別
      • 経口
      • 非経口
      • 鼻腔内
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 企業シェア分析（上位5社およびその他）
  • 市場マップ分析

第6章 北米の家禽用医薬品市場の展望

  • 市場規模の分析・予測
  • 市場シェアの分析・予測
  • 国別市場評価
    • カナダ
    • メキシコ

第7章 欧州の家禽用医薬品市場の展望

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋の家禽用医薬品市場の展望

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米の家禽用医薬品市場の展望

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカの家禽用医薬品市場の展望

  • サウジアラビア
  • UAE
  • 南アフリカ

第11章 需給分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

  • 市場促進要因
  • 市場の課題

第17章 市場動向・展開

第18章 臨床試験の情勢

第19章 規制枠組みとイノベーション

第20章 ケーススタディ

第21章 競合情勢

  • 上位5社の競合マトリックス
  • 上位5社のSWOT分析
  • 上位10社の情勢
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Merck & Co., Inc.
    • Virbac SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Phibro Animal Health Corporation
    • Hester Biosciences Limited
    • Meiji Animal Health Co., Ltd.
    • Venkateshwara Hatcheries Private Limited

第22章 戦略的提言

第23章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 3. Global Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 4. Global Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 5. Global Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 6. Global Poultry Pharmaceuticals Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 9. North America Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 10. North America Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 11. North America Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 12. North America Poultry Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 15. United States Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 16. United States Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 17. United States Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 18. Canada Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 20. Canada Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 21. Canada Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 22. Canada Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 23. Mexico Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 25. Mexico Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 26. Mexico Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 27. Mexico Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 28. Europe Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 30. Europe Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 31. Europe Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 32. Europe Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 33. Europe Poultry Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 36. Germany Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 37. Germany Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 38. Germany Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 39. France Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 41. France Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 42. France Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 43. France Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 44. Italy Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 46. Italy Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 47. Italy Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 48. Italy Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 49. United Kingdom Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 51. United Kingdom Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 52. United Kingdom Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 53. United Kingdom Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 54. Russia Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 56. Russia Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 57. Russia Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 58. Russia Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 59. Netherlands Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 61. Netherlands Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 62. Netherlands Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 63. Netherlands Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 64. Spain Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 66. Spain Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 67. Spain Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 68. Spain Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 69. Turkey Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 71. Turkey Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 72. Turkey Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 73. Turkey Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 74. Poland Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 76. Poland Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 77. Poland Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 78. Poland Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 79. South America Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 81. South America Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 82. South America Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 83. South America Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 84. South America Poultry Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 87. Brazil Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 88. Brazil Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 89. Brazil Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 90. Argentina Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 92. Argentina Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 93. Argentina Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 94. Argentina Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 95. Asia-Pacific Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 97. Asia-Pacific Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 98. Asia-Pacific Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 99. Asia-Pacific Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 100. Asia-Pacific Poultry Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 101. India Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 103. India Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 104. India Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 105. India Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 106. China Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 108. China Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 109. China Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 110. China Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 111. Japan Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 113. Japan Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 114. Japan Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 115. Japan Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 116. Australia Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 118. Australia Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 119. Australia Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 120. Australia Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 121. Vietnam Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 123. Vietnam Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 124. Vietnam Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 125. Vietnam Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 126. South Korea Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 128. South Korea Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 129. South Korea Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 130. South Korea Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 131. Indonesia Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 133. Indonesia Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 134. Indonesia Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 135. Indonesia Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 136. Philippines Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 138. Philippines Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 139. Philippines Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 140. Philippines Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 141. Middle East & Africa Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 143. Middle East & Africa Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 144. Middle East & Africa Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 145. Middle East & Africa Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 146. Middle East & Africa Poultry Pharmaceuticals Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 149. Saudi Arabia Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 150. Saudi Arabia Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 151. Saudi Arabia Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 152. UAE Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 154. UAE Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 155. UAE Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 156. UAE Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 157. South Africa Poultry Pharmaceuticals Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Poultry Pharmaceuticals Market Share (%), By Animal Type, 2018-2032F
  • Figure 159. South Africa Poultry Pharmaceuticals Market Share (%), By Product Type, 2018-2032F
  • Figure 160. South Africa Poultry Pharmaceuticals Market Share (%), By Disease Type, 2018-2032F
  • Figure 161. South Africa Poultry Pharmaceuticals Market Share (%), By Route of Administration, 2018-2032F
  • Figure 162. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Disease Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13544

Global poultry pharmaceuticals market is projected to witness a CAGR of 6.17% during the forecast period 2025-2032, growing from USD 6.56 billion in 2024 to USD 10.59 billion in 2032. The poultry pharmaceutical market functions as an essential component of animal health, which creates and distributes medications, together with health products and vaccines for poultry. The market plays a vital role in protecting poultry health while protecting against diseases and producing safe food products. The market serves commercial poultry operations together with smaller producers because it treats various health conditions, which include bacterial and viral diseases, as well as parasitic diseases and nutritional deficiencies.

The market delivers essential products, which include antibiotics together with antivirals and vaccines and probiotics, and feed additives that promote immunity and growth. The industry now focuses on phytogenic solutions together with vaccines and precision health management because of growing antimicrobial resistance concerns. The regulatory frameworks establish product safety standards, and the efficacy standards and biosecurity protocols work to stop disease outbreaks. The industry expands because of two main factors: rising poultry needs and improved farming approaches, and enhanced knowledge of zoonotic diseases. Developing nations experience rapid market expansion because of growing poultry production, while developed nations direct their focus toward advanced therapeutic solutions and sustainable agricultural practices. The future development of poultry pharmaceuticals will follow biotechnology and diagnostic improvements to create specific and effective treatment options. The industry remains dynamic by prioritizing disease control, maximum productivity, and ethical farming practices.

Additionally, to support the market expansion of the poultry pharmaceuticals market, companies are collaborating to enhance production and quality. For instance, in March 2025, RODEC Pharma Ltd signed an exclusive marketing and distribution agreement with UniFAHS to bring next-generation bacteriophage-based solutions to India's poultry, dairy, and pet health sectors. The increasing threat of antimicrobial resistance (AMR) creates a need for bacteriophage solutions because these treatments naturally fight bacterial infections in livestock without harming animals. The product range targets gut health enhancement, together with immunity building and improved animal performance to enable poultry and livestock farmers to minimize antibiotic use while boosting productivity.

Rising Poultry Consumption Drives Global Poultry Pharmaceuticals Market Growth

The global poultry pharmaceutical market experiences quick growth as consumers choose poultry for their protein meal needs. The expanding global population, together with improved economic conditions in developing regions, makes poultry meat and eggs fundamental food sources which result in expanded poultry farming operations. The rising production requirements generated an increased need for vaccines, together with antibiotics and nutritional supplements, which protect poultry health and optimize flock productivity. Poultry health management depends on pharmaceuticals as a key element because they stop food safety problems and shield birds from avian influenza and other disease outbreaks. The private sector, alongside government departments, makes important investments in modern veterinary medicine and vaccination programs, which stimulate market growth. Food safety standards and consumer preference for antibiotic-free poultry products drive the poultry industry toward developing natural healthcare solutions. The poultry industry's rapid growth will drive continuous pharmaceutical industry expansion, which will create sustainable health products for poultry farming.

For instance, in March 2025, Alembic Pharmaceuticals Ltd. entered into a strategic business partnership with Amlan International, which functions as the animal health division of Oil-Dri Corporation of America, to introduce advanced poultry health solutions and this partnership enables broader distribution of sophisticated feed additives, which improve gut health and enhance nutrient uptake and FCR, and deliver enhanced poultry production outcomes to satisfy increasing protein consumption requirements.

Increase in Causes of Poultry Disease Boosts Global Poultry Pharmaceutical Market Demand

The poultry industries face increasing disease outbreaks, which drive higher demand for pharmaceutical products used in their treatment. Farmers implement preventive and therapeutic solutions because disease outbreaks cause major losses through high bird death rates and lowered egg production, and trade limitations. The market for vaccines, together with antibiotics and antiviral drugs, and disinfectants, has increased because these products help protect poultry flocks from infections. The poultry market expansion is supported by government-backed vaccination programs along with biosecurity protocols implemented by poultry producers. Pharmaceutical companies are expanding production capacities and innovating new treatments to meet rising needs. The increasing consumer knowledge about food safety, combined with disease prevention, has resulted in greater use of modern veterinary medical products. The poultry pharmaceutical business will experience major growth because Asia-Pacific and Africa maintain large poultry operations while battling ongoing disease challenges. Pharmaceutical products demonstrate rising demand because these items protect poultry health, which helps maintain worldwide food supply stability.

For instance, in March 2025, Boehringer Ingelheim International GmbH launched its next-generation three-in-one single-dose innovative solution that defends against Bursal, alongside Newcastle and Marek's diseases.

Chicken Animal Type Holds Largest Global Poultry Pharmaceutical Market Share

The poultry pharmaceutical market maintains its biggest segment through chicken products since large-scale farming operations combine with disease prevention needs. Poultry farming operations around the world raise chickens for their meat and eggs, thus exposing them to numerous diseases. The requirement for vaccines, together with antibiotics and health products, emerges from the need to sustain production levels. Large-scale poultry farms require rigorous vaccination and medication protocols to combat avian influenza and Newcastle disease, and coccidiosis, which are common poultry diseases. The pharmaceutical demand rises because broiler chickens grow quickly, while layer chickens need an extended production time. Various countries enforce vaccination rules to protect food safety, which strengthens the market leadership position. The worldwide demand for chicken protein drives ongoing investments in pharmaceutical solutions that boost production efficiency. The pharmaceutical supply chain for chickens is more extensive and standardized than for turkeys and ducks, thus making chickens the main target for veterinary drug manufacturers. The ongoing increase in poultry consumption will sustain this pattern.

For instance, in March 2025, Merck Animal Health, which operates as MSD Animal Health outside of the United States and Canada, announced the approval of NOBILIS MULTRIVA REOm for chicken protection from the European Commission The vaccine functions by actively immunizing chickens so their offspring receive passive immunity which decreases disease symptoms and viraemia caused by avian reovirus (ARV) genotypes 1 and 4. The vaccine also protects against ARV genotypes 2, 3 and 5.

North America Dominates the Global Poultry Pharmaceuticals Market Share

The North America poultry pharmaceutical market shows clear leadership in the global market because of multiple market-driving factors. The region maintains an advanced industrial poultry market through its large-scale commercial operations, which need effective disease prevention and treatment methods. The high per capita poultry meat and egg consumption in North America leads producers to focus on maintaining flock health and productivity, which drives demand for innovative pharmaceutical solutions. The implementation of strict rules combined with active support for animal welfare and food safety stands as a fundamental requirement. Healthcare providers utilize vaccines together with probiotics and nutraceuticals as alternative health solutions because regulatory frameworks promote responsible antibiotic use. The pharmaceutical industry dedicates substantial funds to research and development, while precision farming technologies and advanced diagnostics experience quick adoption to support the ongoing creation of effective poultry health products.

For instance, in August 2024, Elanco Animal Health Incorporated announced a 2500-square-foot expansion of its biological manufacturing facility in Elwood, Kansas and invest USD 130 million, set to be completed by 2026, will support the growth of its monoclonal antibody (mAb) platform, building on the robust expertise already present at this facility.

Impact of U.S. Tariffs on the Global Poultry Pharmaceuticals Market

The implementation of U.S. poultry pharmaceutical tariffs creates a market disturbance that raises production costs for farmers who need imported vaccines, antibiotics, and supplements to protect their flocks. The increased tariffs create supply chain blockages, which raise prices and generate potential shortages that threaten poultry health and lower production output. The poultry business must decide between absorbing price increases into profit margins or charging consumers more, resulting in decreased market sales of poultry products. Producers will pursue cheaper alternatives that could result in inferior products, which threaten both food safety standards and animal welfare conditions. The combined market pressures will lower poultry production volumes, which will decrease meat and egg supply, thus affecting food security. The poultry industry will suffer major damage from these tariffs if effective countermeasures are not implemented.

Key Players Landscape and Outlook

Continuous innovation, together with strategic market adaptation practices, characterizes the landscape of poultry pharmaceuticals. The sector's companies dedicate extensive funds to research and development for creating better poultry health solutions. The development of new vaccines targets both new and recurring diseases while researchers explore probiotic and phytogenic options to reduce antibiotic use due to antimicrobial resistance concerns. These companies choose geographic expansion as their primary strategy to increase their market presence by targeting the rising poultry industries in developing countries. The collaboration between these companies with academic institutions and other biotech firms and local distributors helps them enhance their abilities to develop products while improving their distribution networks. The companies use technological approaches, which include in-ovo vaccination and advanced diagnostics, along with precision farming methods, to create improved disease management tools for worldwide poultry production of healthier and more productive birds.

For instance, in November 2024, Ceva Animal Health (Ceva) launched its innovative Ceva Genesys for automatic and accurate broiler male and female separation at hatch to achieve better flock homogeneity.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Animal Type
      • 5.2.1.1. Chicken
      • 5.2.1.2. Turkey
      • 5.2.1.3. Others
    • 5.2.2. By Product Type
      • 5.2.2.1. Drugs
        • 5.2.2.1.1. VETRIMOXIN
        • 5.2.2.1.2. Other Drug Products
      • 5.2.2.2. Vaccines
        • 5.2.2.2.1. INNOVAX
        • 5.2.2.2.2. NOBILIS
        • 5.2.2.2.3. Poulvac
        • 5.2.2.2.4. Other Vaccine Products
      • 5.2.2.3. Feed Additives
        • 5.2.2.3.1. VIGOSINE
        • 5.2.2.3.2. Amnovit
        • 5.2.2.3.3. Other Feed Additives
    • 5.2.3. By Disease Type
      • 5.2.3.1. Newcastle Disease
      • 5.2.3.2. Avian Influenza
      • 5.2.3.3. Coccidiosis
      • 5.2.3.4. Salmonella
      • 5.2.3.5. Others
    • 5.2.4. By Route of Administration
      • 5.2.4.1. Oral
      • 5.2.4.2. Parenteral
      • 5.2.4.3. Intranasal
      • 5.2.4.4. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Animal Type
    • 5.3.2. By Product Type
    • 5.3.3. By Disease Type
    • 5.3.4. By Route of Administration
    • 5.3.5. By Region

6. North America Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Animal Type
      • 6.2.1.1. Chicken
      • 6.2.1.2. Turkey
      • 6.2.1.3. Others
    • 6.2.2. By Product Type
      • 6.2.2.1. Drugs
        • 6.2.2.1.1. VETRIMOXIN
        • 6.2.2.1.2. Other Drug Products
      • 6.2.2.2. Vaccines
        • 6.2.2.2.1. INNOVAX
        • 6.2.2.2.2. NOBILIS
        • 6.2.2.2.3. Poulvac
        • 6.2.2.2.4. Other Vaccine Products
      • 6.2.2.3. Feed Additives
        • 6.2.2.3.1. VIGOSINE
        • 6.2.2.3.2. Amnovit
        • 6.2.2.3.3. Other Feed Additives
    • 6.2.3. By Disease Type
      • 6.2.3.1. Newcastle Disease
      • 6.2.3.2. Avian Influenza
      • 6.2.3.3. Coccidiosis
      • 6.2.3.4. Salmonella
      • 6.2.3.5. Others
    • 6.2.4. By Route of Administration
      • 6.2.4.1. Oral
      • 6.2.4.2. Parenteral
      • 6.2.4.3. Intranasal
      • 6.2.4.4. Others
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Poultry Pharmaceuticals Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Animal Type
          • 6.3.1.2.1.1. Chicken
          • 6.3.1.2.1.2. Turkey
          • 6.3.1.2.1.3. Others
        • 6.3.1.2.2. By Product Type
          • 6.3.1.2.2.1. Drugs
          • 6.3.1.2.2.1.1. VETRIMOXIN
          • 6.3.1.2.2.1.2. Other Drug Products
          • 6.3.1.2.2.2. Vaccines
          • 6.3.1.2.2.2.1. INNOVAX
          • 6.3.1.2.2.2.2. NOBILIS
          • 6.3.1.2.2.2.3. Poulvac
          • 6.3.1.2.2.2.4. Other Vaccine Products
          • 6.3.1.2.2.3. Feed Additives
          • 6.3.1.2.2.3.1. VIGOSINE
          • 6.3.1.2.2.3.2. Amnovit
          • 6.3.1.2.2.3.3. Other Feed Additives
        • 6.3.1.2.3. By Disease Type
          • 6.3.1.2.3.1. Newcastle Disease
          • 6.3.1.2.3.2. Avian Influenza
          • 6.3.1.2.3.3. Coccidiosis
          • 6.3.1.2.3.4. Salmonella
          • 6.3.1.2.3.5. Others
        • 6.3.1.2.4. By Route of Administration
          • 6.3.1.2.4.1. Oral
          • 6.3.1.2.4.2. Parenteral
          • 6.3.1.2.4.3. Intranasal
          • 6.3.1.2.4.4. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Poultry Pharmaceuticals Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Clinical Trial Landscape

19. Regulatory Framework and Innovation

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Zoetis Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Elanco Animal Health Incorporated
    • 21.3.3. Merck & Co., Inc.
    • 21.3.4. Virbac SA
    • 21.3.5. Boehringer Ingelheim International GmbH
    • 21.3.6. Ceva Sante Animale
    • 21.3.7. Phibro Animal Health Corporation
    • 21.3.8. Hester Biosciences Limited
    • 21.3.9. Meiji Animal Health Co., Ltd.
    • 21.3.10. Venkateshwara Hatcheries Private Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer